关注
Irina A. Kerle
Irina A. Kerle
Attending physician Translational Medical Oncology
在 nct-dresden.de 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors
S Schwitalla, PK Ziegler, D Horst, V Becker, I Kerle, Y Begus-Nahrmann, ...
Cancer cell 23 (1), 93-106, 2013
3132013
Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA
J Maier, T Lange, I Kerle, K Specht, M Bruegel, C Wickenhauser, P Jost, ...
Clinical Cancer Research 19 (17), 4854-4867, 2013
892013
A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome
S Dehning, N Müller, J Matz, A Bender, I Kerle, J Benninghoff, R Musil, ...
Psychiatric genetics 20 (1), 35-38, 2010
572010
Symptom exacerbation in tourette syndrome due to bacterial reinfection
S Dehning, J Matz, M Riedel, IA Kerle, N Müller
The Journal of clinical psychiatry 70 (11), 20654, 2009
142009
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology
A Mock, MV Teleanu, S Kreutzfeldt, CE Heilig, J Hüllein, L Möhrmann, ...
NPJ Precision Oncology 7 (1), 109, 2023
42023
Circulating tumor DNA profiling of a diffuse large B cell lymphoma patient with secondary acute myeloid leukemia
IA Kerle, L Jägerhuber, R Secci, N Pfarr, P Blüm, R Roesch, KS Götze, ...
Cancers 14 (6), 1371, 2022
32022
Detection of mutant-free circulating tumor DNA in the plasma of patients with gastrointestinal stromal tumor (GIST) harboring activating mutations of C-Kit or PDGFRA.
N von Bubnoff, I Kerle, K Specht, M Bruegel, C Wickenhauser, P Jost, ...
Journal of Clinical Oncology 31 (15_suppl), 10508-10508, 2013
22013
Clinical application of personalized ddPCR assays in liquid profiling of blood and saliva allows early recurrence detection of head and neck tumors
R Rösch, I Kerle, N Pfarr, K Steiger, F Stögbauer, J Rinecker, S Krippgans, ...
Laryngo-Rhino-Otologie 100 (S 02), 2021
12021
Exceptional Response of BRAFV600E-Mutated Acinar Cell CUP to BRAF/MEK Inhibition
IA Kerle, AM Scheuble, B Kobitzsch, G Stocker, GGR Hiller, M Badendick, ...
JCO Precision Oncology 8, e2400030, 2024
2024
Histologieagnostische Tumortherapie–Abschied von den Entitäten?
I Kerle, C Heining
DMW-Deutsche Medizinische Wochenschrift 148 (18), 1174-1181, 2023
2023
Histology-agnostic tumor treatment-a farewell to tumor entities?
I Kerle, C Heining
Deutsche Medizinische Wochenschrift (1946) 148 (18), 1174-1181, 2023
2023
Genomics-based personalized oncology of advanced thymic epithelial tumors
L Möhrmann, L Rostock, M Oleś, A Jahn, M Arlt, N Paramasivam, ...
Cancer Research 83 (7_Supplement), 926-926, 2023
2023
Klinische Anwendung personalisierter ddPCR Assays im Liquid Profiling von Blut und Speichel erlaubt die Rezidivfrüherkennung von Kopf-Hals-Tumoren
R Rösch, I Kerle, N Pfarr, K Steiger, F Stögbauer, J Rinecker, S Krippgans, ...
Laryngo-Rhino-Otologie 100 (S 02), 2021
2021
Cell-Free DNA in Plasma or Saliva for Minimally Invasive Monitoring of Head and Neck Cancer Patients
R Roesch, I Kerle, M Wirth, M Nieberler, N Pfarr, C Mogler, F Stoegbauer, ...
2020
Vergleich der liquid biopsy im Speichel versus Blut bei Patienten mit Plattenepithelkarzinomen des Kopf-Hals-Bereiches
M Wirth, I Kerle, R Rösch, M Nieberler, N Pfarr, C Straube, C Winter
Laryngo-Rhino-Otologie 98 (S 02), 11051, 2019
2019
Comparison of liquid biopsy in saliva versus blood in head and neck squamous cell carcinoma patients
M Wirth, I Kerle, R Rösch, M Nieberler, N Pfarr, C Straube, C Winter
Laryngo-Rhino-Otologie 98 (S 02), 11051, 2019
2019
Liquid biopsy in head and neck cancer: circulating cell-free DNA in plasma and saliva for minimally invasive cancer monitoring
R Roesch, I Kerle, M Wirth, M Nieberler, P Bluem, N Pfarr, C Mogler, ...
ONCOLOGY RESEARCH AND TREATMENT 42, 57-57, 2019
2019
Untersuchung zur Validität der konfokalen Laserimagingmikroskopie zur Beurteilung der Vaskularisierung in einem Mausmodell für das kolorektale Karzinom
IA Kerle
Technische Universität München, 2014
2014
Role of asymmetric kinase dimer formation in EGFR activation and lateral signaling
RK Kancha, N von Bubnoff, I Kerle, J Duyster
ONKOLOGIE 36, 256-256, 2013
2013
Detection of mutant free circulating tumor DNA in the plasma of patients with gastrointestinal stromal tumor (GIST) harboring activating mutations of CKIT or PDGFRA
J Maier, T Lange, I Kerle, K Specht, M Bruegel, C Wickenhauser, P Jost, ...
ONKOLOGIE 36, 179-179, 2013
2013
系统目前无法执行此操作,请稍后再试。
文章 1–20